TABLE 1.

Member Demographics

Member Demographics	N = 21
Gender, female, n	a
Age, at treatment initiation, in years, mean (range)	20.1 (12-51)
Number of CF medications at baseline, mean (SD)b	3.5 (2.1)
Members receiving respiratory medications, excluding respiratory antibiotics, %	81.8
Members receiving respiratory antibiotics, %	59.1
Members receiving gastrointestinal medications, %	68.2
Complications of cystic fibrosis, members, %
0	0
1	14.3
2	19.0
≥ 3	66.7
PDC, mean (SD)	0.62 (0.29)
PDC ≥ 0.8, n	a

^aNot reportable due to cell size < 11.

^bPharmacy claims for medications used to treat CF within 90 days of index date. CF-specific medication has been defined based on the CF pulmonary guidelines as dornase alfa, any inhaled antibiotic, hypertonic saline, oral macrolide antibiotics, ibuprofen, leukotriene modifiers, cromolyn, inhaled beta-adrenergic receptor agonists, inhaled anticholinergics, or N-acetylcysteine.

CF = cystic fibrosis; PDC = proportion of days covered, SD = standard deviation.